RxDoctor Payments Data

Aggy Vallanat

Psychiatry · Jamaica, NYNPI 1417033481

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $908 of the $1,158 with a category attached, or 78.4%. Every reported general payment came from a single manufacturer, Avanir Pharmaceuticals, Inc..

$1,158in general payments, 2019–2025

Across 9 payments — averaging $128.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanir Pharmaceuticals, Inc.$1K
$833,179in research payments, 2019–2025

Across 313 payments — averaging $2661.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$195K
  • AbbVie$141K
  • Boehringer Ingelheim$111K
  • Alkermes, Inc.$108K
  • Takeda Pharmaceuticals U.S.A., Inc.$58K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$48K
  • plus $173K from 10 others

What the payments were for

  • Travel & lodging$90878%
  • Food & beverage$25022%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Avanir Pharmaceuticals, Inc.9$1,158

How this compares

$1,158 in reported general payments places this provider in the 80th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York →

Other psychiatry in Jamaica

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →